Quick Takeaways
- Douglas E. Williams has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $368,957.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Douglas E. Williams and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SANA | Sana Biotechnology, Inc. | EVP & President, R&D | $368,957 | 07 Mar 2024 | ||
| CAMP | Camp4 Therapeutics Corp | Director | 17 Mar 2025 | |||
| CLYM | Climb Bio, Inc. | Director | 04 Jun 2025 | |||
| CDAKQ | Codiak BioSciences, Inc. | President & CEO, Director | 28 Mar 2023 | |||
| OVID | Ovid Therapeutics Inc. | Director | 17 May 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|